Abstract
Hallucinogens of the LSD-type have been used since antiquity (Schultes, 1969, 1970a, b). Peyote and mushrooms containing psilocin (Heim and Wasson, 1958; Wasson, 1959) were used by Indians of the southwestern United States and Central America in religious rites. Lewin (1964) and others conducted experiments with peyote buttons and mescaline at the turn of this century and described their major subjective effects including visual and auditory perceptual changes, some autonomic changes such as perspiration and shivering as well as elevation of mood, which Lewin described as follows: “The individual is usually in a state of extremely good humor and full of feelings of intellectual and physical energy.”
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XXIX. The response index as a measure of threshold activity of psychotropic drugs in man. J. Psychol. (Provmcetown) 48, 65–78 (1959)
Abramson, H.A., Jarvik, M.E., Gorin, M.H., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): XVII. Tolerance development and its relationship to a theory of psychosis. J. Psychol. (Provmcetown) 41, 81–105 (1956)
Abramson, H.A., Jarvik, M.E., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): VIII. Effect upon two measures of motor performance. J. Psychol. (Provincetown) 39, 455–464 (1955c)
Abramson, H.A., Jarvik, M.E., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): X. Effect on reaction time to auditory and visual stimuli. J. Psychol. (Provincetown) 40, 39–52 (1955d)
Abramson, H.A., Jarvik, M.E., Hirsch, M.W., Ewald, A.T.: Lysergic acid diethylamide (LSD-25): V. Effect on spatial relations abilities. J. Psychol. (Provincetown) 39, 435–442 (1955b)
Abramson, H.A., Jarvik, M.E., Kaufman, M.R., Kornetsky, C., Levine, A., Wagner, M.: Lysergic acid diethylamide (LSD-25). I. Physiological and perceptual responses. J. Psychol. (Provincetown) 39, 3–60 (1955a)
Abramson, H.A., Rolo, A., Sklarofsky, B., Stache, J.: Production of cross-tolerance to psychosisproducing doses of lysergic acid diethylamide and psilocybin. J. Psychol. (Provincetown) 49, 151–154 (1960)
Abramson, H.A., Sklarofsky, B.: Lysergic acid diethylamide (LSD-25) antagonists. Arch. gen. Psychiat. 2, 88–93 (1960)
Abramson, H.A., Sklarofsky, B., Baron, M.O., Fremont-Smith, N.: Production of tolerance to psychosis-producing doses of lysergic acid diethylamide. Science 15, 1020 (1957)
Abramson, H.A., Sklarofsky, B., Baron, M.O., Fremont-Smith, N.: Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergie acid diethylamide). Arch. Neurol. Psychiat. (Chic.) 79, 201–207 (1958)
Abramson, H.A., Waxenberg, S.E., Levine, A., Kaufman, M.R., Kornetsky, C.: Lysergic acid diethylamide (LSD-25). XIII. Effect on Bender-Gestalt Test performance. J. Psychol. (Provincetown) 40, 341–349 (1955e)
Adey, W.R., Bell, F.R., Dennis, B. J.: Effects of LSD-25, psilocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat. Neurology (Minneap.) 12, 591–602 (1962)
Adey, W.R, Porter, R., Walter, D.O., Brown, T.S.: Prolonged effects of LSD on EEG records during discriminative performance in cat: Evaluation by computer analysis. Electroenceph. clin. Neurophysiol. 18, 25–35 (1965)
Aghajanian, G.K., Foote, W.E., Sheard, M.H.: Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe. Science 161, 706–708 (1968)
Aghajanian, G.K., Foote, W.E., Sheard, M. H.: Action of psychotogenic drugs on single midbrain raphe neurons. J. Pharmacol. exp. Ther. 171, 178–187 (1970)
Aghajanian, G.K., Haigler, H.J., Bloom, F.E.: Lysergic acid diethylamide and serotonin: Direct actions on serotonin containing neurons in rat brain. Life Sci. 1, 615 (1972)
Aghajanian, G.K., Weiss, B.L.: Block by LSD of the increase in brain serotonin turnover induced by elevated ambient temperature. Nature (Lond.) 220, 759–796 (1968)
Alles, G.A.: Some relations between chemical structure and physiological action of mescaline and related compounds. In: Abramson, H.A. (Ed.): Neuropharmacology. New York: Josiah Macy Jr. Foundation 1959
Altaian, J.L., Appel, J.B.: Effects of LSD on fixed-interval responding in the rat. Proceedings, 79th Annual Convention, American Psychological Association, 1971
Altaian, J.L., Appel, J.B.: LSD and fixed-interval responding in the rat. Pharmacol. Biochem. Behav. 3, 151–155 (1975)
Amin, A.H.T., Crawford, T.B.B., Gaddum, J.H.: Distribution of substance P and 5-hydroxytryptamine in central nervous system in dog. J. Physiol. (Lond.) 126, 596–618 (1954)
Auden, N.-E., Corrodi, H., Fuxe, K.: Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons. J. Pharmacol. exp. Ther. 179, 236–249 (1971)
Auden, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol. 34, 1–7 (1968)
Auden, N.-E., Corrodi, H., Fuxe, K., Meek, J.L.: Hallucinogenic phenylethylamines: Interactions with serotonin turnover and receptors. Europ. J. Pharmacol. 25, 176–184 (1974)
Angrist, B., Rotrosen, J., Gershon, S.: Assessment of tolerance to the hallucinogenic effects of DOM. Psychopharmacologia (Berl.) 36, 203–207 (1974)
Appel, J.B.: The effects of “psychotomimetic” drugs on animal behavior. In: Efron, D.H. (Ed.): Psychopharmacology; A Review of Progress, 1957–1967. PHS Publication No. 1836. Washington, D.C.: U.S. Government Printing Office 1968
Appel, J.B.: Effects of LSD on time-based schedules of reinforcement. Psychopharmacologia (Berl.) 21, 174–186 (1971)
Appel, J.B., Freedman, D.X.: Chemically-induced alterations in the behavioral effects of LSD-25. Biochem. Pharmacol. 13, 861–869 (1964)
Appel, J.B., Freedman, D.X.: Tolerance and cross-tolerance among psychotomimetic drugs. Psychopharmacologia (Berl.) 13, 267–274 (1968)
Appel, J.B., Freedman, D., X., Filby, Y.M.: The effects of three psychoactive drugs on two varieties of escape behavior. Arch. int. Pharmacodyn. 167, 179–193 (1967)
Appel, J.B., Lovell, R.A., Freedman, D.X.: Alterations in the behavioral effects of LSD by pretreatment with p-chlorophenylalanine and α-methyl-p-tyrosine. Psychopharmacologia (Berl.) 18, 387–406 (1970)
Appel, J.B., Whitehead, W.E., Freedman, D.X.: Motivation and the behavioral effects of LSD. Psychon. Sci. 12, 305–306 (1968)
Apter, J.T., Pfeiffer, C.C.: The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram. Ann. N. Y. Acad. Sci. 66, 508–514 (1957)
Arnold, O.H., Hofmann, G., Leupold-Löwenthal, H.: Untersuchungen zum Schizophrenieproblem. IV. Mitteilung: Die Verteilung des C-14-radioaktiven lyserg-säurediäthylamids (C-14-LSD-25) im tierischen Organismus. Wien. Z. Nervenheilk. 15, 15–27 (1958)
Aronson, H., Klee, G.D.: Effect of lysergic acid diethylamide (LSD-25) on impulse control. J. nerv. ment. Dis. 131, 536–539 (1960)
Aston, R., Cullumbine, H.: The effects of combinations of ataraxics with hypnotics, LSD and iproniazid in the mouse. Arch. int. Pharmacodyn. 126, 219–227 (1960)
Axelrod, J., Brady, R.O., Witkop, B., Evarts, E.V.: The distribution and metabolism of lysergic acid diethylamide. Ann. N. Y. Acad. Sci. 66, 435–444 (1957)
Bailey, P.T., Pradhan, S.N.: Effects of Δ 9-tetrahydrocannabinol and mescaline on self-stimulation. Neuropharmacology 11, 831–838 (1972)
Balestrieri, A.: Crossed tolerance between LSD-25 and mescaline. In: Garattini, S., Ghetti, V. (Eds.): Psychotropic Drugs. Amsterdam: Elsevier Publishing Company 1957
Balestrieri, A.: Studies on cross tolerance with LSD-25, UML-491 and JB-336. Psychopharmacologia (Berl.) 1, 257–269 (1960)
Balestrieri, A., Fontanari, D.: Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. Arch. gen. Psychiat. 1, 279–282 (1959)
Barratt, E.S., Pray, S.L.: Effect of a chemically depressed amygdala on the behavioral manifestations produced in cats by LSD-25. Exp. Neurol. 12, 173–178 (1965)
Becker, D.I., Appel, J.B., Freedman, D.X.: Some effects of lysergic acid diethylamide on visual discrimination in pigeons. Psychopharmacologia (Berl.) 11, 354–364 (1967)
Bell, J.A., Martin, W.R.: Studies of tryptamine and lysergic acid diethylamide (LSD) on cutaneous C-fiber and polysynaptic reflexes in the cat. J. Pharmacol. exp. Ther. 190, 492–500 (1974)
Bell, J.A., Martin, W.R., Sloan, J.W., Buchwald, W.F.: The effect of L-tryptophan on spinal cord C-fiber reflexes. J. Pharmacol. exp. Ther. 196, 373–379 (1976)
Belleville, R.E.: MMPI score changes induced by lysergic acid diethylamide (LSD-25). J. clin. Psychol. 12, 279–282 (1956)
Bennett, I.P. and Snyder, S.H.: Serotonin and lysergic acid diethylamide binding in rat brain membranes; relationship to postsynaptic serotonin receptors. Mol. Pharmacol. 12, 373–389 (1976)
Berde, B., Cerletti, A.: Über den Melanophoreneffekt von d-lysergsäure-diäthylamid und verwandten Verbindungen. Helv. physiol. pharmacol. Acta 14, 325–333 (1956)
Bergen, I.R.: Suppression of lysergic acid diethylamide (LSD) effects in pregnant rats. Res. Commun. chem. Pathol. Pharmacol. 3, 313–319 (1972)
Bergen, J.R., Krus, D., Pincus, G.: Suppression of LSD-25 effects in rats by steroids. Proc. Soc. exp. Biol. (N. Y.) 105, 254–256 (1960)
Bergen, J.R., Perkins, L., Hayano, M.: Action of steroids on lysergic acid diethylamide (LSD) metabolism. Proc. Soc. exp. Biol. (N. Y.) 111, 427–428 (1962)
Beringer, K.: La intoxicacion por la mescalina. Arch. argent. Neurol. 2, 145–154 (1928)
Bertino, J.R., Klee, G.D., Collier, D., Weintraub, W.: Clinical studies with dibenzyline and lysergic acid diethylamide. J. clin. exp. Psychopath. 21, 293–299 (1960)
Bertino, J.R., Klee, G.D., Weintraub, W.: Effects of certain vitamins and histamines on the LSD psychosis. J. ment. Sci. 105, 1095–1099 (1959)
Bevan, P., Bradshaw, C.M., Roberts, M.H.T., Szabadi, E.: The effect of microelectrophoretically applied mescaline on cortical neurones. Neuropharmacology 13, 1033–1045 (1974)
Bignami, G.: Facilitation of avoidance asquisition by LSD-25; possible effects on drive modulating systems. Psychopharmacologia (Berl.) 25, 146–151 (1972)
Bishop, P.O., Burke, W., Hayhow, W.R.: Lysergic acid diethylamide block of lateral geniculate synapses and relief by repetitive stimulation. Exp. Neurol. 1, 556–568 (1959)
Bishop, P.O., Field, G., Hennessy, B.L., Smith, J.R.: Action of d-lysergic acid diethylamide on lateral geniculate synapses. J. Neurophysiol. 21, 529–549 (1958)
Bloom, F.E., Costa, E., Salmoiraghi, G.C.: Analysis of individual rabbit olfactory bulb neuron responses to the microelectrophoresis of acetylcholine, norepinephrine and serotonin synergists and antagonists. J. Pharmacol. exp. Ther. 146, 16–23 (1964)
Boakes, R.J., Bradley, P.B., Briggs, I., Dary, A.: Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Brit. J. Pharmacol. 40, 202–218 (1970)
Boardman, W.K., Goldstone, S., Lhamon, W.T.: Effects of lysergic acid diethylamide (LSD) on the time sense of normals. Arch. Neurol. Psychiat. (Chicago) 78, 321–324 (1957)
Bogdanski, D.F., Pletscher, A., Brodie, B.B., Udenfriend, S.: Identification and assay of serotonin in brain. J. Pharmacol. exp. Ther. 117, 82–88 (1956)
Böszörmenyi, Z.: Psilocybin and diethyltryptamine: Two tryptamine hallucinogens. Neuro-psychopharm. 2, 226–229 (1960)
Böszörmenyi, Z., Dér, P., Nagy, T.: Observations on the psychotogenic effect of N-N diethyltryptamine, anew tryptamine derivative. J. ment. Sci. 105, 171–181 (1959)
Bowers, M.B., Jr.: Acute psychosis induced by psychotomimetic drug abuse. II. Neurochemical findings. Arch. gen. Psychiat. 27, 440–442 (1972)
Bradley, P. B., Elkes, J.: The effects of some drugs on the electrical activity of the brain. Brain 80, 77–117 (1957)
Bradley, P.B., Flugel, F., Hoch, P.H. (Eds.): Neuro-Psychopharmacology. New York: Elsevier Publishing Company 1964
Bradley, P.B., Hance, A.J.: The effect of chlorpromazine and methopromazine on the electrical activity of the brain in the cat. Electroenceph. clin. Neurophysiol. 9, 191–215 (1957)
Bradley, P.B., Key, B.J.: The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brain. Electroenceph. clin. Neurophysiol. 10, 97–110 (1958)
Bradshaw, C.M., Roberts, M.H.T., Szabadi, E.: Effect of mescaline on single cortical neurones. Brit. J. Pharmacol. 43, 871–873 (1971)
Brawley, P. and Duffield, I.C.: The pharmacology of hallucinogens. Pharmacol. Rev. 24, 31–66 (1972)
Brimblecombe, R.W.: Effects of psychotropic drugs on open-field behaviour in rats. Psychopharmacologia (Berl.) 4, 139–147 (1963)
Brimblecombe, R.W.: Hyperthermic effects of some tryptamine derivatives in relation to their behavioural activity. Int. J. Neuropharmacol. 6, 423–429 (1967)
Brücke, F., Gogoläk, G., Stumpf, Ch.: Die Wirkung von LSD auf die Makro- und Mikrotätigkeit des Hippocampus. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 240, 461–468 (1961)
Burger, A. (Ed.): Drugs affecting the central nervous system. New York: Marcel Dekker, Inc. 1968
Butters, N.: The effect of LSD-25 on spatial and stimulus perseverative tendencies in rats. Psych opharmacologia (Berl.) 8, 454–460 (1966)
Cameron, O.G., Appel, J.B.: Conditioned suppression of bar-pressing behavior by stimuli associated with drugs. J. exp. Anal. Behav. 17, 127–137 (1972)
Cerletti, A.: Lysergic acid diethylamide (LSD) and related compounds. In: Abramson, H.A. (Ed.): Neuropharmacology. (Transactions of the Second Conference, May 25, 26, and 27, Princeton, N. J.). New York: Josiah Macy, Jr. Foundation 1956
Cervoni, P., Bertino, J.R., Geiger, L.E.: Medullary vagal effects of d-lysergic acid diethylamide in the decerebrate cat. Nature (Lond.) 199, 700–701 (1963)
Chapman, L.F., Walter, R.D.: Actions of lysergic acid diethylamide on averaged human cortical evoked responses to light flash. In: Wortis, J. (Ed.): Recent Advances in Biological Psychiatry. Vol. 7. New York: Plenum Press 1965
Chase, T.N., Breese, G.R., Kopin, I.J.: Serotonin release from brain slices by electrical stimulation: Regional differences and effect of LSD. Science 157, 1461–1463 (1967)
Cholden, L. (Ed.): Lysergic acid diethylamide and mescaline in experimental psychiatry. New York: Grune & Stratton 1956
Cholden, L.S., Kurland, A., Savage, C.: Clinical reactions and tolerance to LSD in chronic schizophrenia. J. nerv. ment. Dis. 122, 211–221 (1955)
Cimbura, G.: PMA deaths in Ontario. Canad. med. Ass. J. 110, 1263–1267 (1974)
Clark, L.D., Bliss, E.L.: Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication: Effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine. Arch. Neurol. Psychiat. (Chic.) 78, 653–655 (1957)
Clineschmidt, B.V., Lotti, V.J.: Indoleamine antagonists: Relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses. Brit. J. Pharmacol. 50, 311–313 (1974)
Cohen, S.: Psychotomimetic agents. Ann. Rev. Pharmacol. 7, 301–318 (1967)
Cole, J.M., Pieper, W.A.: The effects of N, N-dimethyltryptamine on operant behavior in squirrel monkeys. Psychopharmacologia (Berl.) 29, 107–112 (1973)
Cole, J.O., Freedman, A.M., Friedhoff, A.J. (Eds.): Psychopathology and psychopharmacology. Baltimore: Johns Hopkins University Press 1973
Collier, H.O.J.: A general theory of the genesis of drug dependence by induction of receptors. Nature (Lond.) 205, 181–182 (1965)
Cook, L., Weidley, E.: Behavioral effects of some psychopharmacological agents. Ann. N. Y. Acad. Sci. 66, 740–752 (1957)
Cooper, P.D., Walters, G.C.: Stereochemical requirements of the mescaline receptor. Nature (Lond.) 238, 96–98 (1972)
Corne, S.J., Pickering, R.W.: A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacologia (Berl.) 11, 65–78 (1967)
Costa, E: The effects of hallucinogenic and tranquilizing drugs on the serotonin evoked uterine contractions. Psychiat. Res. Rep. Amer. psychiat. Ass. 4, 11–23 (1956)
Crighel, E., Stoica, E.: Cercetâri asupra focarului mescalinic sigmoidian. Stud. Cercet. Neurol. 6, 547–555 (1961)
Crighel, E., Stoica, E.: Cercetâri asupra rolului unor sisteme aferente in declansarea activitatii unui focar convulsiv. Stud. Cercet. Neurol. 7, 173–179 (1962)
Curtis, D.R., Davis, R.: Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat. Brit. J. Pharmacol. 18, 217–246 (1962)
Davis, M., Sheard, M.H.: Effects of lysergic acid diethylamide (LSD) on habituation and sensitization of the startle response in the rat. Pharmacol. Biochem. Behav. 2, 675–683 (1974a)
Davis, M., Sheard, M.H.: Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex. Pharmacol. Biochem. Behav. 2, 827–829 (1974b)
Dear, E.M.A., Malcolm, J.L.: A study of the effect of 3, 4-dimethoxyphenylethylamine on cortical evoked potentials in the rat. Int. J. Neuropharmacol. 6, 529–542 (1967)
De Baran, L., Gogolak, G., Longo, V.G., Stumpf, Ch.: The action of tryptamine upon the electrical activity of single hippocampal neurons. J. Pharmacol. exp. Ther. 139, 337–344 (1963)
DeLaTorre, J.C.: Effect of LSD-25 on the septal region of the rat brain. Nature (Lond.) 219, 954–955 (1968)
Delay, J., Lhermitte, F., Verdeaux, G., Verdeaux, J.: Modifications de l’electrocorticogramme du lapin par la diethylamide de l’acide d-lysergique (LSD 25). Rev. neurol. 86, 81–90 (1952)
De Maar, E.W.J., Williams, H.L., Miller, A.I., Pfeiffer, C.C.: Effects in man of single and combined oral doses of reserpine, iproniazid and d-lysergic acid diethylamide. Clin. Pharmacol. Ther. 1, 23–30 (1960)
Depoortere, H., Loew, D.M.: Alterations in sleep/wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25). Brit. J. Pharmacol. 41, 402P (1971)
Dewhurst, W.G., Marley, E.: The effects of α-methyl derivatives of noradrenaline, phenylethylamine and tryptamine on the central nervous system of the chicken. Brit. J. Pharmacol. 25, 682–704 (1965a)
Dewhurst, W.G., Marley, E.: Action of sympathomimetic and allied amines on the central nervous system of the chicken. Brit. J. Pharmacol. 25, 705–727 (1965b)
Dhawan, B.N.: Blockade of LSD-25 pyrexia by morphine. Arch. int. Pharmacodyn. 127, 307–313 (1960)
Dhawan, B.N., Gupta, G.P.: LSD-25 antagonism of morphine analgesia. Arch. int. Pharmacodyn. 123, 132–139 (1959)
Dhawan, B.N., Gupta, G.P.: Antiemetic activity of d-lysergic acid diethylamide. J. Pharmacol. exp. Ther. 133, 137–139 (1961)
Diab, I.M., Freedman, D.X., Roth, L.J.: [3H]lysergic acid diethylamide: Cellular autoradiographic localization in rat brain. Science 173, 1022–1024 (1971)
Dimascio, A., Greenblatt, M., Hyde, R.W.: A study of the effects of LSD: Physiologic and psychological changes and their interrelations. Amer. J. Psychiat. 114, 309–317 (1957)
DiStefano, V., Leary, D.E.: Effect of LSD on inhibitory systems in the spinal cord. Fed. Proc. 17, 364 (1958)
Ditman, K.S., Whittlesey, J.R.B.: Comparison of the LSD-25 experience and delirium tremens. Arch. gen. Psychiat. 1, 47–57 (1959)
Dixon, A.K.: Evidence of catecholamine mediation in the “aberrant” behaviour induced by lysergic acid diethylamide (LSD) in the rat. Experientia (Basel) 24, 743–747 (1968)
Domer, F.R., Longo, V.G.: Effect of 5-hydroxytryptophan on the cerebral electrical activity of the rabbit. Arch. int. Pharmacodyn. 136, 204–218 (1962)
Domino, E.F., Bartolini, A.: Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats. Neuropharmacology 11, 703–713 (1972)
Dykstra, L.A., Appel, J.B.: Effects of LSD on auditory perception: A signal detection analysis. Psychopharmacologia (Berl.) 34, 289–307 (1974)
Edwards, A.E., Cohen, S.: Visual illusion, tactile sensibility and reaction time under LSD-25. Psychopharmacologia (Berl.) 2, 297–303 (1961)
Efron, D.H. (Ed.): Psychopharmacology; a review of progress, 1957–1967. PHS Publication No. 1836. Washington, D.C.: U.S. Government Printing Office 1968
Efron, D.H. (Ed.): Psychotomimetic drugs. New York: Raven Press 1970
Efron, D.H., Holmstedt, B., Kline, N.S. (Eds.): Ethnopharmacologic search for psychoactive drugs. PHS Publication No. 1645. Washington, D.C.: U.S. Government Printing Office 1967
Elder, J.T., Jr., Dille, J.M.: An experimental study of the participation of the sympathetic nervous system in the lysergic acid diethylamide (LSD) reaction in cats. J. Pharmacol. exp. Ther. 136, 162–168 (1962)
Elder, J.T., Shellenberger, M.K.: Antagonism of lysergic acid diethylamide (LSD)-induced hyperthermia. J. Pharmacol. exp. Ther. 136, 293–297 (1962)
Elkes, J.: Drugs influencing effect and behavior: Possible neural correlates in relation to mode of action. In: Smith, A., Herbert, C.C., Straus, R. (Eds.): The physiology of emotions. Springfield, Ill: Charles C.Thomas 1961
Elkes, J., Elkes, C., Bradley, P.B.: The effect of some drugs on the electrical activity of the brain, and on behaviour. J. ment. Sci. 100, 125–128 (1954)
Etevenon, P.R., Boissier, J.R.: LSD effects on signal-to-noise ratio and lateralization of visual cortex and lateral geniculate during photic stimulation. Experientia (Basel) 28, 1338–1340 (1972)
Evarts, E.V.: Some effects of bufotenine and lysergic acid diethylamide on the monkey. Arch. Neurol. Psychiat. (Chic.) 75, 49–53 (1956)
Evarts, E.V.: A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other psychotomimetic agents. Ann. N. Y. Acad. Sci. 66, 479–495 (1957)
Evarts, E.V.: Effects of a series of indoles on synaptic transmission in the lateral geniculate nucleus of the cat. In: Pennes, H.H. (Ed.): Progress in neurobiology. 3. Psychopharmacology. New York: Hoeber-Harper 1958a
Evarts, E.V.: Neurophysiological correlates of pharmacologically-induced behavioral disturbances. In: Solomon, H.C., Cobb, S., Penfield, W. (Eds.): The brain and human behavior. Res. Publ. nerv. ment. Dis., Vol. 36. Baltimore: Williams & Wilkins 1958b
Evarts, E.V., Landau, W., Freygang, W., Jr., Marshall, W.H.: Some effects of lysergic acid diethylamide and bufotenine on electrical activity in the cat’s visual system. Amer. J. Psychol. 182, 594–598 (1955)
Fabing, H.D.: On going beserk: A neurochemical inquiry. Amer. J. Psychiat. 113, 409–415 (1956)
Fabing, H.D., Hawkins, J.R.: Intravenous bufotenine injection in the human being. Science 123, 886–887 (1956)
Faillace, L.A., Snyder, S.H., Weingartner, H.: 2,5-Dimethoxy-4-methylamphetamine: Clinical evaluation of a new hallucinogenic drug. J. nerv. ment. Dis. 150, 119–126 (1970)
Falkenberg, G.: The molecular structure of some psychoactive indolealkylamines and related substances. Stockholm: Tryckeri Balder AB 1972
Farrow, J.T., van Vunakis, H.: Binding of d-lysergic acid diethylamide to subcellular fractions from rat brain. Nature (Lond.) 237, 164–166 (1972)
Farrow, J.T., van Vunakis, H.: Characteristics of d-lysergic acid diethylamide binding to subcellular fractions derived from rat brain. Biochem. Pharmacol. 22, 1103–1113 (1973)
Fischer, R.: Space-time coordinates of excited and tranquilized states. In: Jakob, K. (Ed.): Psychiatry and art. Proceedings IVth Int. Coll. Psychopathology of Expression. Basel-New York: S. Karger 1968
Fish, B., Campbell, M., Shapiro, T., Floyd, A., Jr.: Schizophrenic children treated with methysergide (Sansert). Dis. nerv. Syst. 30, 534–540 (1969)
Florio, V., Lipparini, F., De Carolis, A.S., Longo, V.G.: EEG and behavioral effects of 2, 5-methoxy-4-methyl-amphetamine (DOM, STP). Arch. int. Pharmacodyn. 180, 81–88 (1969)
Forrer, G.R., Goldner, R.D.: Experimental physiological studies with lysergic acid diethylamide (LSD-25). Arch. Neurol. Psychiat. (Chic.) 65, 581–588 (1951)
Freedman, D.X.: Effects of LSD-25 on brain serotonin. J. Pharmacol. exp. Ther. 134, 160–166 (1961)
Freedman, D.X., Aghajanian, G.K., Ornitz, E.M., Rosner, B.S.: Patterns of tolerance to lysergic acid diethylamide and mescaline in rats. Science 127, 1173–1174 (1958)
Freedman, D.X., Appel, J.B., Hartman, F.R., Molliver, M.E.: Tolerance to behavioral effects of LSD-25 in rat. J. Pharmacol. exp. Ther. 143, 309–313 (1964)
Freedman, D.X., Giarman, N.J.: LSD-25 and the status and level of brain serotonin. Ann. N. Y. Acad. Sci. 96, 98–106 (1962)
Freeman, H.: Pupil dilatation in normal and schizophrenic subjects following lysergic acid diethylamide ingestion. Arch. Neurol. Psychiat. (Chic.) 79, 341–344 (1958)
Friedman, H., Carey, R.J.: Effects of LSD-25 on performance of a visual discrimination task in brain-damaged rats. Pharmacol. Biochem. Behav. 3, 421–424 (1975)
Friedman, S.A., Hirsch, S.E.: Extreme hyperthermia after LSD ingestion. J. Amer. med. Ass. 217, 1549–1550 (1971)
Fujimori, M., Himwich, H.E.: Electroencephalographic alerting sites of d-amphetamine and 2, 5-dimethoxy-4-methyl-amphetamine. Nature (Lond.) 220, 491–494 (1968)
Fuster, J.M.: Lysergic acid and its effects on visual discrimination in monkeys. J. nerv. ment. Dis. 129, 252–256 (1959)
Gaddum, J.H.: Tryptamine receptors. J. Physiol. (Lond.) 119, 363–368 (1953)
Gaddum, J.H., Hameed, K. A.: Drugs which antagonize 5-hydroxytryptamine. Brit. J. Pharmacol. 9, 240–248 (1954)
Gaddum, J.H., Picarelli, Z.P.: Two kinds of tryptamine receptor. Brit. J. Pharmacol. 12, 323–328 (1957)
Gaddum, J.H., Vogt, M.: Some central actions of 5-hydroxytryptamine and various antagonists. Brit. J. Pharmacol. 11, 175–179 (1956)
Garattini, S., Ghetti, V. (Eds.): Psychotropic drugs. New York: Elsevier Publishing Company 1957
Gardner, E.L.: Effects of LSD-25 on bar-pressing behavior in the hooded rat. Psychon. Sci. 3, 507–508 (1965)
Gastaut, H., Ferrer, S., Castells, C.: Action de la diéthylamide de l’acide d-lysergique (LSD 25) sur les fonctions psychiques et l’électroencéphalogramme. Confin. neurol. (Basel) 13, 102–120 (1953)
Geiger, L.E., Cervoni, P.: Effect of d-lysergic acid diethylamide on spinal reflexes. Proc. Soc. exp. Biol. (N.Y.) 99, 179–181 (1958)
Gelder, M.G., Vane, J.R.: Interaction of the effects of tyramine, amphetamine and reserpine in man. Psychopharmacologia (Berl.) 3, 231–241 (1962)
Gessner, P.K., Page, I.H.: Behavioral effects of 5-methoxy-N, N-dimethyltryptamine, other tryptamines, and LSD. Amer. J. Physiol. 203, 167–172 (1962)
Giberti, F., Gegoretti, L.: Prime esperienze di antagonismo psicofarmacologico Psicosi sperimentale da LSD e trattemanto con cloropromazine e reserpina. Sist. nerv. 4, 301–310 (1955)
Gillin, J.C., Cannon, E., Magyar, R., Schwartz, M., Wyatt, R.J.: Failure of N, N-dimethyltryptamine to evoke tolerance in cats. Biol. Psychiat. 7, 213–220 (1973)
Ginzel, K.H.: Some central effects of lysergic acid diethylamide on vasomotor responses. J. Physiol. (Lond.) 129, 61P–62P (1955)
Ginzel, K.H.: The effect of lysergic acid diethylamide on some autonomic reflex patterns: In: Garattini, S., Ghetti, V. (Eds.): Psychotropic drugs. New York: Elsevier Publishing Company 1957
Ginzel, K. H.: The effect of d-lysergic acid diethylamide and other drugs on the carotid sinus reflex. Brit. J. Pharmacol. 13, 250–259 (1958)
Ginzel, K.H., Mayer-Gross, W.: Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148). Nature (Lond.) 178, 210 (1956)
Glow, P.H.: Some acute effects of d-lysergic acid diethylamide on the rat. Quart. J. exp. Psychol. 9, 206–214 (1957)
Gogerty, J.H., Dille, J.M.: Tolerance to the pyretogenic effects of lysergic acid diethylamide. J. Pharmacol. exp. Ther. 116, 450–452 (1956)
Gogerty, J.H., Dille, J.M.: Pharmacology of d-lysergic acid morpholide (LSM). J. Pharmacol. exp. Ther. 120, 340–348 (1957)
Goldman, H., Fischer, R., Nicolov, N., Murphy, S.: Lysergic acid diethylamide affects blood flow to specific areas of the conscious rat brain. Experientia (Basel) 31, 328–329 (1975)
Goldstein, L., Murphree, H.B., Sugerman, A.A., Pfeiffer, C.C., Jenney, E.H.: Quantitative electroencephalographic analysis of naturally occurring (schizophrenic) and drug-induced psychotic states in human males. Clin. Pharmacol. Ther. 4, 10–21 (1963)
Gonzalez-Vegas, J.A.: Antagonism of catecholamine inhibition of brain stem neurones by mescaline. Brain Res. 35, 264–267 (1971)
Gorodetzky, C.W., Isbell, H.: A comparison of 2, 3-dihydro-lysergic acid diethylamide with LSD-25. Psychopharmacologia (Berl.) 6, 229–233 (1964)
Green, W.J.: The effect of LSD on the sleep-dream cycle. J. nerv. ment. Dis. 140, 417–426 (1965)
Greenberg, M.J.: Structure-activity relationship of tryptamine analogues on the heart of Venus mercenaria. Brit. J. Pharmacol. 15, 375–388 (1960)
Greiner, T., Burch, N.R., Edelberg, R.: Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. Arch. Neurol. Psychiat. (Chicago) 79, 208–210 (1958)
Guttmann, E., Maclay, W.S.: Mescalin and depersonalization: Therapeutic experiments. J. Neurol. Psychopath. 16, 193–212 (1936)
Gyermek, L.: Drugs which antagonize 5-hydroxytryptamine and related indolealkylamines. In: Eichler, O., Farah, A. (Eds.): 6-Hydroxytryptamine and related indolealkylamines. Handbook of experimental pharmacology, Vol. 19. Berlin-Heidelberg-New York: Springer 1966
Haertzen, C.A.: Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol. Rep. 18, 163–194 (1966)
Haigler, H.J., Aghajanian, G.K.: Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain. Europ. J. Pharmacol. 21, 53–60 (1973)
Hale, A.R., Reed, A.F.: Prophylaxis of frequent vascular headache with methysergide. Amer. J. med. Sci. 243, 92–98 (1962)
Haley, T.J.: Pharmacological effects from drugs injected intracerebrally in unanesthetized animals. J. Amer. pharm. Ass. 45, 604–607 (1956)
Haley, T.J.: Intracerebral injection of psychotomimetic and psychotherapeutic drugs into conscious mice. Acta pharmacol. (Kbh.) 13, 107–112 (1957a)
Haley, T.J.: 5-Hydroxytryptamine antagonism by lysergic acid diethylamide after intracerebral injection in conscious mice. J. Amer. pharm. Ass. 46, 428–430 (1957b)
Haley, T.J., Dasgupta, S.R.: Intracerebral injection of lysergic acid diethylamide in conscious dogs and cats. Arch. int. Pharmacodyn. 113, 296–301 (1958)
Haley, T.J., Rutschmann, J.: Brain concentrations of LSD-25 (Delysid) after intracerebral or intravenous administration in conscious animals. Experientia (Basel) 13, 199–202 (1957)
Hamilton, C.L.: Effects of LSD-25 and amphetamine on a running response in the rat. Arch. gen. Psychiat. 2, 104–109 (1960)
Hamilton, C.L., Wilpizeski, C.: Effects of LSD-25 on food intake in the rat. Proc. Soc. exp. Biol. (N.Y.) 108, 319–321 (1961)
Hartman, A.M., Hollister, L.E.: Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception. Psychopharmacologia (Berl.) 4, 441–451 (1963)
Heim, R., Wasson, R.G.: Les champignons hallucinogenes du Mexique. Etudes ethnologiques, taxinomiques, biologiques, physiologiques et chimiques. Paris: Muséum National d’Histoire Naturelle 1958
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Jr., Miner, E.J.: The Addiction Research Center Inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine. Psychopharmacologia (Berl.) 4, 167–183 (1963a)
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Jr., Miner, E.J.: The Addiction Research Center Inventory: Appendix. I. Items comprising empirical scales for seven drugs. II. Items which do not differentiate placebo from any drug condition. Psychopharmacologia (Berl.) 4, 184–205 (1963b)
Himmelsbach, C.K.: Morphine. IV. With reference to physical dependence. Fed. Proc. 2, 201–203 (1943)
Himwich, H.E. (Ed.): Biochemistry, schizophrenias and affective illnesses. Baltimore: Williams & Wilkins Company 1971
Hirschhorn, I.D., Winter, J.C.: Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia (Berl.) 22, 64–71 (1971)
Hirschhorn, I.D., Winter, J.C.: Differences in the stimulus properties of barbital and hallucinogens. Pharmacol. Biochem. Behav. 3, 343–347 (1975)
Hobson, J.A.: The effect of LSD on the sleep cycle of the cat. Electroenceph. clin. Neurophysiol. 17, 52–56 (1964)
Hoch, P.H.: Experimental psychiatry. Amer. J. Psychiat. 111, 787–790 (1955)
Hoch, P.H., Cattell, J.P., Pennes, H.H.: Effects of mescaline and lysergic acid (d-LSD-25). Amer. J. Psychiat. 108, 579–584 (1952)
Hoffer, A., Osmond, H. (Eds.): The hallucinogens. New York: Academic Press 1967
Hollister, L.E.: Clinical, biochemical and psychologic effects of psilocybin. Arch. int. Pharmacodyn. 130, 42–52 (1961)
Hollister, L.E.: Chemical psychoses. LSD and related drugs. Springfield: Charles C. Thomas 1968
Hollister, L.E., Friedhoff, A.J.: Effects of 3, 4-dimethoxyphenylethylamine in man. Nature (Lond.) 210, 1377–1378 (1966)
Hollister, L.E., Hartman, A.M.: Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures. Comprehend Psychiat. 3, 235–241 (1962)
Hollister, L.E., Macnicol, M.F., Gillespie, H.K.: An hallucinogenic amphetamine analog (DOM) in man. Psychopharmacologia (Berl.) 14, 62–73 (1969)
Hollister, L.E., Sjoberg, B.M.: Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs. Comprehens. Psychiat. 5, 170–178 (1964)
Hollunger, G., Persson, S.A.: The effect of LSD and 2-bromo LSD on the DOPA accumulation after central and peripheral decarboxylase inhibition. Europ. J. Pharmacol. 31, 156–158 (1975)
Horita, A., Dille, J.M.: Pyretogenic effect of lysergic acid diethylamide. Science 120, 1100–1101 (1954)
Horita, A., Gogerty, J.H.: The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of LSD. J. Pharmacol. exp. Ther. 122, 195–200 (1958)
Horita, A., Hamilton, A.E.: Lysergic acid diethylamide: Dissociation of its behavioral and hyperthermic actions by DL-α-methyl-p-tyrosine. Science 164, 78–79 (1969)
Horita, A., Hamilton, A.E.: The effects of DL-α-methyltyrosine and L-DOPA on the hyperthermic and behavioral actions of LSD in rabbits. Neuropharmacology 12, 471–476 (1973)
Horita, A., Hill, H.F.: Hallucinogens, amphetamines and temperature regulation. In: Schoenbaum, E., Lomax, T. (Eds.): The pharmacology of thermoregulation. Symposium, San Francisco, 1972. Basel: Karger 1972
Horn, G., McKay, J.M.: Effects of lysergic acid diethylamide on the spontaneous activity and visual receptive fields of cells in the lateral geniculate nucleus of the cat. Exp. Brain Res. 17, 271–284 (1973)
Huxley, A.: The doors of perception. New York: Harper & Row 1954
Ingvar, D.H., Soderberg, U.: The effect of LSD-25 upon the cerebral blood flow and EEG in cats. Experientia (Basel) 12, 427–428 (1956)
Isbell, H.: Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia (Bed.) 1, 29–38 (1959)
Isbell, H., Belleville, R.E., Fraser, H.F., Wikler, A., Logan, C.R.: Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication. Arch. Neurol. Psychiat. (Chicago) 76, 468–478 (1956)
Isbell, H., Fraser, H. F., Wikler, A., Belleville, R.E.: Tolerance to diethylamide of lysergic acid (LSD-25). Fed. Proc. 14, 21 (1955)
Isbell, H., Gorodetzky, C.W.: Effect of alkaloids of ololiuqui in man. Psychopharmacologia (Berl.) 8, 331–339 (1966)
Isbell, H., Jasinski, D.R.: A comparison of LSD-25 with (-)-Δ 9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacologia (Berl.) 14, 115–123 (1969)
Isbell, H., Logan, C.R.: Studies on the diethylamide of lysergic acid (LSD-25). II. Effects of chlorpromazine, azacyclonol, and reserpine on the intensity of the LSD-reaction. Arch. Neurol. Psychiat. (Chicago) 77, 350–358 (1957)
Isbell, H., Logan, C.R., Miner, E.J.: Studies on lysergic acid diethylamide (LSD-25). III. Attempts to attenuate the LSD-reaction in man by pretreatment with neurohumoral blocking agents. Arch. Neurol. Psychiat. (Chic.) 81, 20–27 (1959a)
Isbell, H., Miner, E.J., Logan, C.R.: Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia (Berl.) 1, 20–28 (1959b)
Isbell, H., Miner, E.J., Logan, C.R.: Cross tolerance between d-2-Brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25). Psychopharmacologia (Berl.) 1, 109–116 (1959c)
Isbell, H., Rosenberg, D.E., Miner, E.J., Logan, C.R.: Tolerance and cross tolerance to scopolamine, N-ethyl-3-piperidyl benzylate (JB-318) and LSD-25. Neuropsychopharmacology 3, 440–446 (1964)
Isbell, H., Wolbach, A.B., Wikler, A., Miner, E.J.: Cross tolerance between LSD and psilocybin. Psychopharmacologia (Berl.) 2, 147–159 (1961)
Jacob, J.: Quelques réactions enzymatiques conduisant à des substances hallucinogènes. Thérapie 20, 252–259 (1965)
Jacob, J., Lafille, C.: Characterisation et détection pharmacologiques des substances hallucinogénes. I. Activites hyperthermisantes chez le lapin. Arch. int. Pharmacodyn. 145, 528–545 (1963)
Jacob, J., Lafille, C.: Antagonistes de l’action hyperthermisante du lysergamide chez de lapin. Proc. 2nd int. pharmacol. Meet. 2, 249–261 (1964)
Jacob, J., Lafille, C., Loiseau, G., Echinard-Garin, P., Barthelemy, C.: Recherche d’équivalents expérimentaux au pouvoir hallucinogène; Action des hallucinogènès sur la température rectale du lapin et sur les effets de la morphine chez la souris. Med. exp. (Basel) 7, 296–304 (1962)
Jacob, J., Loiseau, G., Echinard-Garin, P., Barthelemy, C., Lafille, C.: Caractérisation et détection pharmacologiques des substances hallucinogènes. II.—Antagonismes vis-a-vis de la morphine chez la souris. Arch. int. Pharmacodyn. 148, 14–30 (1964)
Jacobsen, E.: The clinical pharmacology of the hallucinogens. Clin. Pharmacol. Ther. 4, 480–503 (1963)
Jaffe, J.H., Sharpless, S.K.: The rapid development of physical dependence on barbiturates. J. Pharmacol. exp. Ther. 150, 140–145 (1965)
Jarrard, L.E.: Effects of D-lysergic acid diethylamide on operant behavior in the rat. Psychopharmacologia (Berl.) 5, 39–46 (1963)
Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): IV. Effect on attention and concentration. J. Psychol. (Provincetown) 39, 373–383 (1955a)
Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Lysergic acid diethylamide (LSD-25): VI. Effect upon recall and recognition of various stimuli. J. Psychol. (Provincetown) 39, 443–454 (1955b)
Jarvik, M.E., Abramson, H.A., Hirsch, M.W.: Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25). J. abnorm. soc. Psychol. 51, 657–662 (1955d)
Jarvik, M.E., Abramson, H.A., Hirsch, M.W., Ewald, A.T.: Lysergic acid diethylamide (LSD-25): VIII. Effect on arithmetic test performance. J. Psychol. (Provincetown) 39, 465–473 (1955c)
Jarwik, M.E., Chorover, S.: Impairment by lysergic acid diethylamide of accuracy in performance of a delayed alternation test in monkeys. Psychopharmacologia (Berl.) 1, 221–230 (1960)
Kang, S., Green, J.P.: Correlation between activity and electronic state of hallucinogenic amphetamines. Nature (Lond.) 226, 645 (1970a)
Kang, S., Green, J.P.: Steric and electronic relationships among some hallucinogenic compounds. Proc. nat. Acad. Sci. (Wash.) 67, 62–67 (1970b)
Kay, D.C., Martin, W.R., Croughan, J.L.: The electrocorticographic and cardiovascular effects of tryptamine and LSD in the encephale isole cat. In preparation (1976)
Keeler, M.H.: The effects of psilocybin on a test of after-image perception. Psychopharmacologia (Berl.) 8, 131–139 (1965a)
Keeler, M.H.: Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods. Int. J. Neuropsychiat. 1, 630–634 (1965b)
Keller, D.L., Umbreit, W.W.: “Permanent” alteration of behavior in mice by chemical and psychological means. Science 124, 723–724 (1956)
Keup, W. (Ed.): Origin and mechanisms of hallucinations. New York: Plenum Press 1970
Key, B.J.: Effects of chlorpromazine and lysergic acid diethylamide on the rate of habituation of the arousal response. Nature (Lond.) 190, 275–277 (1961a)
Key, B.J.: The effect of drugs on discrimination and sensory generalisation of auditory stimuli in cats. Psychopharmacologia (Berl.) 2, 352–363 (1961b)
Key, B.J.: The effect of LSD-25 on the interaction between conditioned and non-conditioned stimuli in a simple avoidance situation. Psychopharmacologia (Berl.) 6, 319–326 (1964)
Khazan, N, McCash, D.: Effects of LSD-25, N, N-dimethyltryptamine (DMT), and N, N-diethyl-tryptamine (DET) on the photic evoked responses in the unanesthetized rabbit. Arch. int. Pharmacodyn. 154, 474–483 (1965)
Khazan, N., Sawyer, C.H.: Mechanisms of paradoxical sleep as revealed by neurophysiologic and pharmacologic approaches in the rabbit. Psychopharmacologia (Berl.) 5, 457–466 (1964)
Kies, M.W., Horst, D., Evarts, E.V., Goldstein, N.P.: Antidiuretic effect of lysergic acid diethylamide in humans. Arch. Neurol. Psychiat. (Chic.) 77, 267–269 (1957)
Killam, E.K.: Drug action on the brain-stem reticular formation. Pharmacol. Rev. 14, 175–223 (1962)
Killam, K.F., Killam, E.K.: The action of lysergic acid diethylamide on central afferent and limbic pathways in the cat. J. Pharmacol. exp. Ther. 116, 35–36 (1956)
King, A.R., Martin, I.L., Melville, K.A.: Reversal learning enhanced by lysergic acid diethylamide (LSD): Concomitant rise in brain 5-hydroxytryptamine levels. Brit. J. Pharmacol. 52, 419–426 (1974)
Klee, G.D., Bertino, J., Callaway, E., III, Weintraub, W.: Clinical studies with LSD-25 and two substances related to serotonin. Part I. Clinical reactions of normal human subjects given LSD-25 and an antimetabolite of serotonin (1 benzyl-2, 5-dimethylserotonin hydrochloride) (BAS). J. ment. Sci. 106, 301–305 (1960)
Klee, G.D., Bertino, J., Weintraub, W., Callaway, E., III: The influence of varying dosage on the effects of lysergic acid diethylamide (LSD-25) in humans. J. nerv. ment. Dis. 132, 404–409 (1961)
Kluver, H.: Mechanisms of hallucinations. In: Studies in personality. New York: McGraw-Hill 1942
Koella, W.P., Beaulieu, R.F., Bergen, J.R.: Stereotyped behavior and cyclic changes in responses produced by LSD in goats. Int. J. Neuropharmacol. 3, 397–403 (1964)
Koella, W.P., Wells, C.-H.: Influence of LSD-25 on optically evoked potentials in the nonanes-thetized rabbit. Amer. J. Physiol. 196, 1181–1184 (1959)
Koelle, G.B.: The pharmacology of mescaline and d-lysergic acid diethylamide (LSD). New Engl. J. Med. 258, 25–32 (1958)
Korein, J., Musacchio, J.M.: LSD and focal cerebral lesions. Behavioral and EEG effects in patients with sensory defects. Neurology (Minneap.) 18, 147–152 (1968)
Kostowski, W.: Evoked synchronization and desynchronization in the EEG of the cat. Diss. pharm. pharmacol. 23, 471–479 (1971)
Kreindler, A., Crighel, E., Sotirescu, N.: Modificärile räspunsului cortical direct produse do mescalina si reserpina. Stud. Cercet. Neurol. 7, 287–296 (1962)
Krivoy, W.: The preservation of substance P by lysergic acid diethylamide. Brit. J. Pharmacol. 12, 361–364 (1957)
Krivoy, W.A.: Potentiation of substance P by lysergic acid diethylamide in vivo. Brit. J. Pharmacol. 16, 253–256 (1961)
Kmjevic, K., Phillis, J.W.: Actions of certain amines on cerebral cortical neurones. Brit. J. Pharmacol. 20, 471–490 (1963)
Krus, D.M., Wapner, S., Bergen, J., Freeman, H.; The influence of progesterone on behavioral changes induced by lysergic acid diethylamide (LSD-25) in normal males. Psychopharmacologia (Berl.) 2, 177–184 (1961)
Ladefoged, O.: The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats. Arch. int. Pharmacodyn. 204, 326–332 (1973)
Laidlaw, P.P.: The physiological action of indolethylamine. Biochem. J. 6, 141–150 (1912)
Landis, C., Clausen, J.: Certain effects of mescaline and lysergic acid on psychological functions. J. Psychol. (Provincetown) 38, 211–221 (1954)
Langfitt, T.W., Finney, L.A.: Effects of lysergic acid diethylamide (LSD) on cortical sensory evoked potentials in the cat. Arch. Neurol. (Chic.) 1, 258–268 (1959a)
Langfitt, T.W., Finney, L.A.: Effects of LSD on cortex of cat correlated with changes in vital signs. Arch. Neurol. (Chic.) 1, 269–281 (1959b)
Leonard, B.E., Tonge, S.R.: The effects of some hallucinogenic drugs upon the metabolism of noradrenaline. Life Sci. 8, 815–825 (1969)
Levine, A., Abramson, H.A., Kaufman, M.R., Markham, S.: Lysergic acid diethylamide (LSD-25): XVI. The effect on intellectual functioning as measured by the Wechsler-Bellevue Intelligence Scale. J. Psychol. (Provincetown) 40, 385–395 (1955)
Levis, D.J., Caldwell, D.F.: The effects of a low dosage of mescaline and 3, 4-dimethoxyphen-ylethylamine under two levels of aversive stimulation. Biol. Psychiat. 3, 251–257 (1971)
Lewin, L.: Phantastica: Narcotic and stimulating drugs; their use and abuse. New York: E. P. Dutton&Co. 1964
Liebert, R.S., Werner, H., Wapner, S.: Studies in the effect of lysergic acid diethylamide (LSD-25); self- and object-size perception in schizophrenics and normal adults. Arch. Neurol. Psychiat. (Chic.) 79, 580–584 (1958)
Lin, R.C., Ngai, S.H., Costa, E.: Lysergic acid diethylamide: Role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine). Science 166, 237–239 (1969)
Lindsley, D.F., Carpenter, R.S., Killam, E.K., Killam, K.F.: EEG correlates of behavior in the cat. I. Pattern discrimination and its alteration by atropine and LSD-25. Electroenceph. clin. Neurophysiol. 24, 497–513 (1968)
Linton, H.B., Langs, R.J.: Subjective reactions to lysergic acid diethylamide (LSD-25); measured by a questionnaire. Arch. gen. Psychiat. 6, 352–368 (1962)
Little, K.D., DiStefano, V., Leary, D.E.: LSD and serotonin effects on spinal reflexes in the cat. J. Pharmacol. exp. Ther. 119, 161 (1957)
Little, M.D., Dill, R.E.: Mescaline and other O-methylated β-phenylethylamines: Intrastriatal induction of tremor in rats. Brain Res. 13, 360–366 (1969)
Loew, D.M., Depoortere, H., Vigouret, J.M.: Wirkungen von d-lysergsäurediäthylamid (LSD-25) und 2-brom-d-lysergsäurediäthylamid (BOL-148) auf das Schlafverhalten der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 266, 394–395 (1970)
Longo, V.G.: Epinephrine and drugs acting on adrenergic receptors; 5-hydroxytryptamine and related compounds. In: Longo, V.G. (Ed.): Electroencephalographic atlas for pharmacological research; effect of drugs on the electrical activity of the rabbit brain. Rabbit Brain Research, Vol. 2. New York: Elsevier Publishing Company 1962
Lowe, G., Williams, D.I.: The effect of LSD-25 on light-reinforced behaviour in the rat. Psychopharmacologia (Berl.) 27, 255–263 (1972)
Mahler, DJ., Humoller, F.L.: Effect of lysergic acid diethylamide and bufotenine on performance of trained rats. Proc. Soc. exp. Biol. (N. Y.) 102, 697–701 (1959)
Malitz, S., Esecover, H., Wilkens, B., Hoch, P.H.: Some observations on psilocybin, a new hallucinogen, in volunteer subjects. Comprehens. Psychiat. 1, 8–17 (1960)
Malmnäs, C.O.: Monaminergic influence on testosterone-activiated copulatory behavior in the castrated male rat. Acta physiol. scand., Suppl. 395 (1973)
Marchbanks, R.M.: Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles. Biochem. Pharmacol. 16, 1971–1979 (1967).
Marczynski, T.J.: Lysergic acid diethylamide (LSD-25) mimicks the effect of diffuse light input on EEG correlates of conditioned operant behavior in cats. Exp. Neurol. 34, 255–263 (1972)
Marrazzi, A.S.: The effects of certain drugs on cerebral synapses. Ann. N.Y. Acad. Sci. 66, 496–507 (1957)
Marrazzi, A.S., Hart, E.R.: Relationship of hallucinogens to adrenergic cerebral neurohumors. Science 121, 365–367 (1955)
Martin, W.R.: A homeostatic and redundancy theory of tolerance to and dependence on narcotic analgesics. In: Wikler, A. (Ed.): The addictive states. Res. Publ. Ass. nerv. ment. Dis., Vol. 46. Baltimore: Williams and Wilkins 1968
Martin, W.R.: Assessment of the abuse potentiality of amphetamines and LSD-like hallucinogens in man and its relationship to basic animal assessment programs. In: Goldberg, L., Hoffmeister, F. (Eds.): Psychic dependence. Definition, assessment in animals and man. Theoretical and clinical implications. Berlin-Heidelberg-New York: Springer 1973
Martin, W.R., Eades, C.G.: Pharmacological studies of spinal cord adrenergic and cholinergic mechanisms and their relation to physical dependence on morphine. Psychopharmacologia (Berl.) 11, 195–223 (1967)
Martin, W.R., Eades, C.G.: The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens. Psychopharmacologia (Berl.) 17, 242–257 (1970)
Martin, W.R., Eades, C.G.: Cross tolerance to tryptamine in the LSD tolerant dog. Psychopharmacologia (Berl.) 27, 93–98 (1972)
Martin, W.R., Eades, C.G.: Effects of phenethylamine (PEA) in the chronic spinal dog. Pharmacologist 16, 205 (1974)
Martin, W.R., Eades, C.G.: Effects of β-phenethylamine in the chronic spinal dog. In preparation (1976)
Martin, W.R., Sloan, J.W.: Effects of infused tryptamine in man. Psychopharmacologia (Berl.) 18, 231–237 (1970)
Martin, W.R., Sloan, J.W.: The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens. Mt. Sinai J. Med. (N.Y.) 41, 276–282 (1974)
Martin, W.R., Sloan, J.W., Buchwald, W.F., Bridges, S.R.: The demonstration of tryptamine in regional perfusates of the dog brain. Psychopharmacologia (Berl.) 37, 189–198 (1974)
Martin, W.R., Sloan, J.W., Buchwald, W.F., Clements, T.H.: Neurochemical evidence for tryptaminergic ascending and descending pathways in the spinal cord of the dog. Psychopharmacologia (Berl.) 43, 131–134 (1975)
Martin, W.R., Sloan, J.W., Christian, S.T., Clements, T.H.: Brain levels of tryptamine. Psychopharmacologia (Berl.) 24, 331–346 (1972)
Martin, W.R., Sloan, J.W., Vaupel, D.B., Bell, J.A., Nozaki, M.: Tryptamine in the brain and spinal cord: Its role in the LSD response. In: Usdin, E., Sandler, M. (Eds.): Trace amines and the brain. New York: Marcel Dekker 1976
Matussek, N., Halbach, A.: Über den Einfluß von Ergotamin auf die LSD-“Psychose” beim Menschen. Psychopharmacologia (Berl.) 5, 158–160 (1964)
McKay J.M., Horn, G.: Effects of LSD on receptive fields of single cells in the lateral geniculate nucleus of the cat. Nature (Lond.) 229, 347–349 (1971)
Meldrum, B.S., Naquet, R.: Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon. Electroenceph. clin. Neurophysiol. 31, 563–572 (1971)
Mendels, J.: The effect of methysergide (an antiserotonin agent) on schizophrenia: A preliminary report. Amer. J. Psychiat. 124, 849–852 (1967)
Merlis, S., Denber, H.C.B.: Studies on mescaline. V. Electroencephalographic evidence for the antagonism between mescaline and chlorpromazine hydrochloride. J. nerv. ment. Dis. 123, 542–545 (1956)
Miller, R.C., Miller, E.K.: Lack of a long-term effect of LSD on Y-maze learning in mice. Nature (Lond.) 228, 1107–1108 (1970)
Mison-Crighel, N., Luca, N., Crighel, E.: The effect of an epileptogenic focus, induced by topical application of mescaline, on glutamic acid, glutamine and GABA in the neocortex of the cat. J. Neurochem. 11, 333–340 (1964)
Monroe, R.R., Heath, R.G.: Effects of lysergic acid and various derivatives on depth and cortical electrograms. J. Neuropsychiat. 3, 75–82 (1961)
Monroe, R.R., Heath, R.G., Mickle, W.A., Llewellyn, R.C.: Correlation of rhinencephalic electrograms with behavior. A study on humans under the influence of LSD and mescaline. Electroenceph. clin. Neurophysiol. 9, 623–642 (1957)
Mouriz-Garcia, A., Schmidt, R., Arlazoroff, A.: Effects of LSD on the spontaneous and evoked activity of retinal and geniculate ganglion cells. Psychopharmacologia (Berl.) 15, 382–391 (1969)
Nandy, K., Bourne, G.H.: The effects of D-lysergic acid diethylamide tartrate (LSD-25) on the cholinesterases and monamine oxidase in the spinal cord: A possible factor in the mechanism of hallucination. J. Neurol. Neurosurg. Psychiat. 27, 259–267 (1964)
Naranjo, C., Shulgin, A.T., Sargent, T.: Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Med. Pharmacol. exp. 17, 359–364 (1967)
Neff, N., Rossi, G.V., Chase, G.D., Rabinowitz, J.L.: Distribution and metabolism on mescaline-C14 in the cat brain. J. Pharmacol. exp. Ther. 144, 1–7 (1964)
Neuhold, K., Taeschler, M., Cerletti, A.: Beitrag zur zentralen Wirkung von LSD: Versuche über die Lokalisation von LSD-Effekten. Helv. physiol. pharmacol. Acta 15, 1–7 (1957)
Nozaki, M., Vaupel, D.B., Martin, W.R.: A pharmacologic comparison of 3,4-methylenedioxy-amphetamine and LSD in the chronic spinal dog. In preparation (1976a).
Nozaki, M., Vaupel, D.B., Martin, W.R.: A pharmacologic comparison of 2-methyl-3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog. In preparation (1976b)
Palmer, G.C., Burks, T.F.: Central and peripheral adrenergic blocking actions of LSD and BOL. Europ. J. Pharmacol. 16, 113–116 (1971).
Passouant, P., Passouant-Fontaine, Th., Cadilhac, J.: Action du L.S.D. 25 sur le comportement et les rythmes corticaux et rhinencephaliques du chat chronique. C. R. Soc. Biol. (Paris) 150, 2237–2241 (1956)
Paton, D.M.: Effect of amphetamine, 3,4-methylenedioxyamphetamine, p-methoxyamphetamine and related amphetamines on uptake of metaraminol and efflux of noradrenaline in adrenergic nerves of rabbit atria. J. Pharm. Pharmacol. 27, 361–362 (1975)
Paton, W.D.M.: A theory of drug action based on the rate of drug-receptor combination. Proc. roy.Soc.B 154, 21–69 (1961)
Pawlowski, A.A.: Effects of lysergic acid diethylamide on the modification of a learned jumping response. J. Neuropsychiat. 4, 81–86 (1962)
Peretz, D.I., Smythies, J.R., Gibson, W.C.: A new hallucinogen: 3,4,5-trimethoxyphenyl-β-aminopropane; with notes on the stroboscopic phenomenon. J. ment. Sci. 101, 317–329 (1955)
Peters, D.A.V.: Comparison of the chronic and acute effects of d-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine. Biochem. Pharmacol. 23, 231–237 (1974)
Philips, S.R., Durden, D.A., Boulton, A.A.: Identification and distribution of tryptamine in the rat. Canad. J. Biochem. 52, 447–451 (1974)
Pickworth, W.B., Sharpe, L.G.: The transcallosally evoked potential following administration of LSD, mescaline, DMT, apomorphine and methoxamine in the dog. Fed. Proc. 35, 270 (1976)
Pieri, L., Pieri, M., Haefely, W.: LSD as an agonist of dopamine receptors in the striatum. Nature (Lond.) 252, 586–588 (1974)
Purpura, D.P.: Electrophysiological analysis of psychotogenic drug action. I. Effect of LSD on specific afferent systems in the cat. Arch. Neurol. Psychiat. (Chic.) 75, 122–131 (1956a)
Purpura, D.P.: Electrophysiological analysis of psychotogenic drug action. II. General nature of lysergic acid diethylamide (LSD) action on central synapses. Arch. Neurol. Psychiat. (Chic.) 75, 132–143 (1956b)
Purpura, D.P.: Neurophysiological action of LSD. In: De Bold, R.C., Leaf, R.C. (Eds.): LSD, man & society. Middletown, Conn.: Wesleyan University Press 1967
Richards, K.C., Borgstedt, H.H.: Near fatal reaction to ingestion of the hallucinogenic drug MDA. J. Amer. med. Ass. 218, 1826–1827 (1971)
Richards, N., Chapman, L.F., Goodell, H., Wolff, H.G.: LSD-like delirium following ingestion of a small amount of its brom analog (BOL-148). Ann. intern. Med. 48, 1078–1083 (1958)
Rinaldi, F., Himwich, H.E.: The cerebral electrographic changes induced by LSD and mescaline are corrected by Frenquel. J. nerv. ment. Dis. 122, 424–432 (1955a)
Rinaldi, F., Himwich, H.E.: Frenquel corrects certain cerebral electrographic changes. Science 122, 198–199 (1955b)
Rinkel, M., DeShon, H.J., Hyde, R.W., Solomon, H.C.: Experimental schizophrenia-like symptoms. Amer. J. Psychiat. 108, 572–578 (1952)
Roberts, M.H.T., Straughan, D.W.: Excitation and depression of cortical neurones by 5-hydroxytryptamine. J. Physiol. (Lond.) 193, 269–294 (1967)
Roberts, M.H.T., Straughan, D.W.: Actions of noradrenaline and mescaline on cortical neurones. Naunyn-Schmiedebergs Arch. exp. Pharmak. 259, 191–192 (1968)
Rodin, E., Luby, E.: Effects of LSD-25 on the EEG and photic evoked responses. Arch. gen. Psychiat. 14, 435–441 (1966)
Rosecrans, J.A., Lovell, R.A., Freedman, D.X.: Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem. Pharmacol. 16, 2011–2021 (1967)
Rosenberg, D.E., Isbell, H., Miner, E.J.: Comparison of a placebo, N-dimethyltryptamine and 6-hydroxy-N-dimethyltryptamine in man. Psychopharmacologia (Berl.) 4, 39–42 (1963a)
Rosenberg, D.E., Isbell, H., Miner, E.J., Logan, C.R.: The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia (Berl.) 5, 217–227 (1964)
Rosenberg, D.E., Wolbach, A.B. Jr., Miner, E.J., Isbell, H.: Observations on direct and cross tolerance with LSD and D-amphetamine in man. Psychopharmacologia (Berl.) 5, 1–15 (1963b)
Roszell, D.K., Horita, A.: The effects of haloperidol and thioridazine on apomorphine- and LSD-induced hyperthermia in the rabbit. J. psychiat. Res. 12, 117–123 (1975)
Roth, W.T.: The effect of LSD, mescaline, and d-amphetamine on the evoked “secondary discharge”. Psychopharmacologia (Berl.) 9, 253–258 (1966)
Rothlin, E.: Lysergic acid diethylamide and related substances. Ann. N. Y. Acad. Sci. 66, 668–676 (1957a)
Rothlin, E.: Pharmacology of lysergic acid diethylamide and some of its related compounds. J. Pharm. Pharmacol. 9, 569–587 (1957b)
Rothlin, E., Cerletti, A.: Über einige pharmakologische Untersuchungen an Mäusen mit congenitaler Drehsucht. Helv. physiol. pharmacol. Acta 10 319–327 (1952)
Rothlin, E., Cerletti, A.: Pharmacology of LSD-25. In: Cholden, L. (Ed.): Lysergic acid diethylamide and mescaline in experimental psychiatry. New York: Grune & Stratton 1956
Rothlin, E., Cerletti, A., Konzett, H., Schalen, W.R., Taeschler, M.: Zentrale vegetative LSD-Effekte. Experientia (Basel) 12, 154 (1956)
Rovetta, P.: Effect of mescaline and L.S.D. on evoked responses especially of the optic system of the cat. Electroenceph. clin. Neurophysiol. 8, 15–24 (1956)
Rubin, B., Piala, J.J., Burke, J.C., Craver, B.N.: A new, potent and specific serotonin inhibitor, (SQ 10, 643) 2′-(3-dimethylaminopropylthio) cinnamanilide hydrochloride: Antiserotonin activity on uterus and on gastrointestinal, vascular, and respiratory systems of animals. Arch. int. Pharmacodyn. 152, 132–143 (1964)
Saavedra, J.M., Axelrod, J.: Psychotomimetic N-methylated tryptamines: Formation in brain in vivo and in vitro. Science 175, 1365–1366 (1972a)
Saavedra, J.M., Axelrod, J.: A specific and sensitive enzymatic assay for tryptamine in tissues. J. Pharmacol. exp. Ther. 182, 363–369 (1972b)
Saavedra, J.M., Axelrod, J.: Effect of drugs on the tryptamine content of rat tissues. J. Pharmacol. exp. Ther. 185, 523–529 (1973)
Safer, D.J.: The effect of LSD on sleep-deprived men. Psychopharmacologia (Berl.) 17, 414–424 (1970)
Sai-Halász, A., Brunecker, G., Szára, S.: Dimethyltryptamin: Ein neues Psychoticum. Psychiat. et Neurol. (Basel) 135, 285–301 (1958)
Salmoiraghi, G.C., McCubbin, J.W., Page, I.H.: Effects of d-lysergic acid diethylamide and its brom derivative on cardiovascular responses to serotonin and on arterial pressure. J. Pharmacol. exp. Ther. 119, 240–247 (1957)
Salomon, K., Gabrio, B.W., Thale, T.: A study on mescaline in human subjects. J. Pharmacol. exp. Ther. 95, 455–459 (1949)
Salvatore, S., Hyde, R.W.: Progression of effects of lysergic acid diethylamide (LSD). Arch. Neurol. Psychiat. (Chic.) 76, 50–59 (1956)
Samanin, R., Valzelli, L., Gumulka, W.: Inhibitory effect of midbrain raphe stimulation on cortical evoked potentials in rats. Psychopharmacologia (Berl.) 24, 373–379 (1972)
Schechter, M.D., Rosecrans, J.A.: Lysergic acid diethylamide (LSD) as a discriminative cue: Drugs with similar stimulus properties. Psychopharmacologia (Berl.) 26, 313–316 (1972)
Schechter, M.D., Winter, J.C.: Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat. J. Pharmacol. exp. Ther. 177, 461–467 (1971)
Schneider, C.: Behavioural effects of some morphine antagonists and hallucinogens in the rat. Nature (Lond.) 220, 586–587 (1968)
Schultes, R.E.: Hallucinogens of plant origin. Science 163, 245–254 (1969)
Schultes, R.E.:The New World Indians and their hallucinogenic plants. Morris Arboretum Bull. 21, 3–14 (1970a)
Schultes, R.E.: The botanical and chemical distribution of hallucinogens. Ann. Rev. Plant Physiol. 21, 571–598 (1970b)
Schwartz, A.S., Cheney, C.: Effect of LSD on the tonic activity of the visual pathways of the cat. Life Sci. 4, 771–778 (1965a)
Schwartz, A.S., Cheney, C.: Retinal effects of high doses of LSD in the cat. Exp. Neurol. 13, 273–282 (1965b)
Schwarz, B.E., Bickford, R.G., Rome, H.P.: Reversibility of induced psychosis with chlorpromazine. Proc. Mayo Clin. 30, 407–417 (1955)
Schwarz, B.E., Sem-Jacobsen, C.W., Petersen, M.C.: Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man. Arch. Neurol. Psychiat. (Chic.) 75, 579–587 (1956b)
Schwarz, B.E., Wakim, K.G., Bickford, R.G., Lichtenheld, E.R.: Behavioral and electroence-phalographic effects of hallucinogenic drugs. Arch. Neurol. Psychiat. (Chic.) 75, 83–90 (1956a)
Schweigerdt, A.K., Himwich, H.E.: An electrographic study of bufotenin and 5-hydroxytryp-tophan. J. Pharmacol. exp. Ther. 144, 253–259 (1964)
Schweigerdt, A.K., Stewart, A.H., Himwich, H.E.: An electrographic study of d-lysergic acid diethylamide and nine congeners. J. Pharmacol. exp. Ther. 151, 353–359 (1966)
Shagass, C.: Effects of LSD on somatosensory and visual evoked responses and on the EEG in man. In: Words, J. (Ed.): Recent advances in biological psychiatry, Vol. 9. New York: Plenum Press 1967
Sharpe, L.G., Otis, L.S., Schusterman, R.J.: Disruption of size discrimination in squirrel monkeys (Saimiri sciureus) by LSD-25. Psychon. Sci. 7, 103–104 (1967)
Shulgin, A.T.: Psychotomimetic amphetamines: Methoxy 3, 4-dialkoxy-amphetamines. Experientia (Basel) 20, 366–370 (1964a)
Shulgin, A.T.: 3-Methoxy-4,5-methylenedioxy amphetamine, a new psychotomimetic agent. Nature (Lond.) 201, 1120–1121 (1964b)
Shulgin, A.T.: The ethyl homologs of 2,4,5-trimethoxyphenylisopropylamine. J. med. Chem. 11, 186–187 (1968)
Shulgin, A.T., Bunnell, S., Sargent, T. III: The psychotomimetic properties of 3,4,5-trimethoxy-amphetamine. Nature (Lond.) 189, 1011–1012 (1961)
Shulgin, A.T., Carter, M.F.: Centrally active phenethylamines. Psychopharmacol. Commun. 1, 93–98 (1975)
Shulgin, A.T., Sargent, T.: Psychotropic phenylisopropylamines derived from apiole and dillapiole. Nature (Lond.) 215, 1494–1495 (1967)
Shulgin, A.T., Sargent, T., Naranjo, C.: Structure-activity relationships of one-ring psychotomimetics. Nature (Lond.) 221, 537–541 (1969)
Shulgin, A.T., Sargent, T., Naranjo, C.: 4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog. Pharmacology 5, 103–107 (1971)
Siegel, R.K., Brewster, J.M., Jarvik, M.E.: An observational study of hallucinogen-induced behavior in unrestrained Macaca mulatta. Psychopharmacologia (Berl.) 40, 211–223 (1974)
Silva, M.T.A., Calil, H.M.: Screening hallucinogenic drugs: Systematic study of three behavioral tests. Psychopharmacologia (Berl.) 42, 163–171 (1975)
Silva, M.T.A., Carlini, E.A., Claussen, U., Korte, F.: Lack of cross-tolerance in rats among (-)(Δ 9- trans-tetrahydrocannabinol (Δ 9-THC), cannabis extract, mescaline and lysergic acid diethyl-amide (LSD-25). Psychopharmacologia (Bed.) 13, 332–340 (1968)
Silverstein, A.B., Klee, G.D.: Effects of lysergic acid diethylamide (LSD-25) on intellectual functions. Arch. Neurol. Psychiat (Chic.) 80, 477–480 (1958)
Sivadjian, J.: L’action du diéthylamide de l’acide lysergique (LSD-25) sur le conditionnement et la sudation. Thérapie 25, 813–821 (1970)
Slater, I.H., Davis, K.H., Leary, D.E., Boyd, E.S.: The action of serotonin and lysergic acid ethylamide on spinal reflexes. J. Pharmacol. exp. Ther. 113, 48–49 (1955)
Sloan, J.W., Martin, W.R., Clements, T.H., Buchwald, W.F., Bridges, S.R.: Factors influencing brain and tissue levels of tryptamine: Species, drugs and lesions. J. Neurochem. 24, 523–532 (1975)
Smith, C.M., Walaszek, E.J.: Interaction of Substance P and other smooth muscle stimulants with LSD-25 on the guinea pig ileum. Arch. int. Pharmacodyn. 138, 429–436 (1962)
Smythies, J.R.: Quantitative measurement of the effect of lysergic acid diethylamide on mice and its interactions with other drugs. Nature (Lond.) 138, 545–546 (1959)
Smythies, J.R.: The mode of action of psychotomimetic drugs. Neurosci. Res. Prog. Bull. 8, 1–152 (1970)
Smythies, J.R., Benington, F., Morin, R.D.: The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain. Int. Rev. Neurobiol. 12, 207–233 (1970)
Smythies, J.R., Bradley, R.J., Johnston, V.S., Benington, F., Morim, R.D., Clark, L.C., Jr.: Structure-activity relationship studies on mescaline. Psychopharmacologia (Berl.) 10, 379–387 (1967a)
Smythies, J.R., Johnston, V.S., Bradley, R.J.: Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behavior change induced by mescaline. Nature (Lond.) 216, 196–197 (1967b)
Smythies, J.R., Koella, W.P., Levy, C.K.: The effect of mescaline on the optic evoked potentials in the unanesthetized rabbit. J. Pharmacol. exp. Ther. 129, 462–470 (1960)
Snodgrass, S.R., Horn, A. S.: An assay procedure for tryptamine in brain and spinal cord using its (3H)dansyl derivative. J. Neurochem. 21, 687–696 (1973)
Snyder, S.H., Faillace, L., Hollister, L.: 2,5-Dimethoxy-4-methyl-amphetamine (STP): A new hallucinogenic drug. Science 158, 669–670 (1967)
Snyder, S.H., Reivich, M.: Regional localization of lysergic acid diethylamide in monkey brain. Nature (Lond.) 209, 1093–1095 (1966)
Snyder, S.H., Richelson, E.: Psychedelic drugs: Steric factors that predict psychotropic activity. Proc. nat. Acad. Sci. (Wash.) 60, 206–213 (1968)
Snyder, S.H., Weingartner, H., Faillace, L.A.: DOET (2,5-dimethoxy-4-ethylamphetamine) and DOM (STP) (2,5-dimethoxy-4-methylamphetamine), new psychotropic agents: Their effects in man. In: Efron, D.H. (Ed.): Psychotomimetic drugs. New York: Raven Press 1970
Snyder, S.H., Weingartner, H., Faillace, L.A.: DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug; effects of varying doses in man. Arch. gen. Psychiat. 24, 50–55 (1971)
Speck, L.B.: Toxicity and effects of increasing doses of mescaline. J. Pharmacol. exp. Ther. 119, 78–84 (1957)
Speck, L.B.: Electroencephalographic changes in the rat with mescaline intoxication. J. Pharmacol. exp. Ther. 122, 201–206 (1958)
Steiner, J.E., Sulman, F.G.: Simultaneous studies of blood sugar, behavioural changes and EEG on the wake rabbit after administration of psilocybin. Arch. int. Pharmacodyn. 145, 301–308 (1963)
Stern, W.C., Morgane, P.J., Bronzino, J.D.: LSD: Effects on sleep patterns and spiking activity in the lateral geniculate nucleus. Brain Res. 41, 199–204 (1972)
Stoff, D.M., Mandel, J.J., Gorelick, D.A., Bridger, W.H.: Acute and chronic effects of LSD and 3,4-dimethoxyphenylethylamine on shuttlebox escape/avoidance in rats. Psychopharmacologia (Berl.) 36, 301–312 (1974)
Stoll, A., Rothlin, E., Rutschmann, J., Schalch, W.R.: Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD-25) in the animal body. Experientia (Basel) 11, 396–397 (1955)
Stoll, W.A.: D-lysergic acid diethylamide (LSD-25), a phantasticum of the ergot group. Schweiz. Arch. Neurol. Psychiat. 60, 1–45 (1947)
Straub, W.: Zur chemischen Kinetik Muskarin Wirkung und des Antagonismus Muskarin-atropin. Pflügers Arch. ges. Physiol. 119, 127–151 (1905)
Stumpf, Ch.: Drug action on septal and hippocampal units. In: Bradley, P.B., Flugel, F., Hoch, P. (Eds.): Neuropharmacology. Amsterdam: Elsevier Publishing Company 1964
Stumpf, Ch., Petsche, H., Gogolak, G.: The significance of the rabbit’s septum as a relay station between the midbrain and the hippocampus. II. The differential influence of drugs upon both the septal cell firing pattern and the hippocampus theta activity. Electroenceph. clin. Neurophysiol. 14, 212–219 (1962)
Sugrue, M. F.: A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs. Brit. J. Pharmacol. 35, 243–252 (1969)
Szara, S.: Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia (Basel) 12, 441–442 (1956)
Szara, S.: The comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in self experiments. In: Garattini, S., Ghetti, V. (Eds.): Psychotropic drugs. Amsterdam: Elsevier Publishing Company 1957
Szara, S.: DMT (N,N-dimethyltryptamine) and homologues: Clinical and pharmacological considerations. In: Efron, D.H. (Ed.): Psychotomimetic drugs. New York: Raven Press 1970
Szara, S., Rockland, L.H., Rosenthal, D., Handlon, J.H.: Psychological effects and metabolism of N,N-diethyltryptamine in man. Arch. gen. Psychiat. 15, 320–329 (1966)
Taeschler, M., Cerletti, A.: Some observations on the interaction of reserpine and LSD. J. Pharmacol. exp. Ther. 120, 179–183 (1957)
Taeschler, M., Weidmann, H., Cerletti, A.: Die Wirkung von LSD auf die Reaktionszeiten bei einer bedingten Fluchtreaktion und im Analgesietest. Helv. physiol. Acta 18, 43–49 (1960)
Takagi, H., Yamamoto, S., Takaori, S., Ogiu, K.: The effect of LSD and reserpine on the central nervous system of the cat. The antagonism between LSD and chlorpromazine or reserpine. Jap. J. Pharmacol. 7, 119–134 (1958)
Takeo, Y., Himwich, H.E.: Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: Sites of electroencephalographic arousal. Science 150, 1309–1310 (1965)
Takeo, Y., Himwich, H.E.: The significance of methyl groups in the electroencephalographic effects of indolealkylamines in the rabbit. Biochem. Pharmacol. 16, 1013–1022 (1967)
Tang, A.H., Uhlinger, B.J., Schroeder, L.A.: Comparison of N,N-diethyltryptamine and U-22,-394A, a new tryptamine derivative. Arch. int. Pharmacodyn. 176, 74–85 (1968)
Taylor, R.L., Maurer, J.I., Tinklenberg, J.R.: Management of “bad trips” in an evolving drug scene. J. Amer. med. Ass. 213, 422–425 (1970)
Tedeschi, D.H., Tedeschi, R.E., Fellows, E.J.: The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazid-like drugs. J. Pharmacol, exp. Ther. 126, 223–232 (1959)
Thiessen, P.N., Cook, D.A.: The properties of 3,4-methylenedioxy-amphetamine (MDA). I. A review of the literature. Clin. Toxicol. 6, 45–52 (1973)
Tilson, H.A., Sparber, S. B.: Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula. J. Pharmacol. exp. Ther. 181, 387–398 (1972)
Tilson, H.A., Sparber, S.B.: Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat. J. Pharmacol. exp. Ther. 184, 376–384 (1973)
Turner, W.J., Merlis, S.: Effect of some indolealkylamines on man. Arch. Neurol. Psychiat. (Chic.) 81, 121–129 (1959)
Twarog, B.M., Page, I.H.: Serotonin content of some mammalian tissues and urine and a method for its determination. Amer. J. Physiol. 175, 157–161 (1953)
Ursin, H.: The lack of effect of LSD-25 on amygdaloid and cortical attention responses. Psychopharmacologia (Bed.) 3, 317–330 (1962)
U.S. Department of Justice, Drug Enforcement Administration: DAWN Management Report, July 1975
Uyeno, E.T.: Effects of mescaline and psilocybin on dominance behavior of the rat. Arch. int. Pharmacodyn. 166, 60–64 (1967a)
Uyeno, E.T.: Lysergic acid diethylamide and dominance behavior of the squirrel monkey. Arch. int. Pharmacodyn. 169, 66–69 (1967b)
Uyeno, E.T.: Hallucinogenic compounds and swimming response. J. Pharmacol. Exp. Ther. 159, 216–221 (1968)
Uyeno, E.T.: Relative potency of amphetamine derivatives and N, N-dimethyltryptamines. Psychopharmacoligia (Berl.) 19, 381–387 (1971)
Uyeno, E.T., Benson, W.M.: Effects of lysergic acid diethylamide on attack behavior of male albino mice. Psychopharmacologia (Berl.) 7, 20–26 (1965)
Uyeno, E.T., Otis, L.S., Mitoma, C.: Behavioral evaluation of hallucinogenic trimethoxy-amphetamines in squirrel monkeys (Saimiri Sciureus). Commun. Behav. Biol. 1, 83–90 (1968)
Vane, J.R.: The actions of sympathomimetic amines on tryptamine receptors. In: Adrenergic mechanisms. CIBA Foundation Symposium. Boston: Little, Brown and Company 1960
Vane, J.R., Collier, H.O.J., Corne, S.J., Marley, E., Bradley, P.B.: Tryptamine receptors in the central nervous system. Nature (Lond.) 191, 1068–1069 (1961)
Vaupel, D.B., Martin, W.R.: Interaction of oxotremorine with atropine, chlorpromazine, cyproheptadine, imipramine and phenoxybenzamine on the flexor reflex of the chronic spinal dog. Psychopharmacologia (Berl.) 30, 13–26 (1973)
Vaupel, D.B., Martin, W.R.: Actions of methoxamine and tryptamine and their interactions with cyproheptadine and phenoxybenzamine on cat spinal cord segmental reflexes. J. Pharmacol. exp. Ther. 196, 87–96 (1976)
Vaupel, D.B., Nozaki, M.: A comparison of the effects of 2, 5-dimethoxyamphetamine (DMA) and lysergic acid diethylamide (LSD) in the dog. Fed. Proc. 34, 767 (1975)
Vaupel, D.B., Nozaki, M., Martin, W.R.: A pharmacologic comparison of 2,5-dimethoxyam-phetamine and LSD in the chronic spinal dog. Drug Alc. Depend. 2, 45–63 (1977)
Verdeaux, G., Marty, R.: Action sur l’electroencephalogramme de substances pharmacodyna-miques d’intert clinique. Rev. neurol. 91, 405–427 (1954)
Vogt, M., Gunn, C.G. Jr., Sawyer, C.H.: Electroencephalographic effects of intraventricular 5-HT and LSD in the cat. Neurology (Minneap.) 7, 559–566 (1957)
Von Hungen, K., Roberts, S., Hill, D.F.: LSD as an agonist and antagonist at central dopamine receptors. Nature (Lond.) 252, 588–589 (1974).
Votava, Z., Glisson, S.N., Himwich, H.E.: Behavioral reaction of rats pretreated with reserpine to LSD-25. Int. J. Neuropharmacol. 6, 543–547 (1967)
Wallach, M.B., Friedman, E., Gershon, S.: 2,5-Dimethoxy-4-methyl-amphetamine (DOM), a neuropharmacological examination. J. Pharmacol. exp. Ther. 182, 145–154 (1972)
Wallach, M.B., Hine, B., Gershon, S.: Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats. Europ. J. Pharmacol. 29, 89–92 (1974)
Walter, S., Balzano, E., Vuillon-Cacciuttolo, G., Naquet, R.: Effects comportementaux et electrographiques du diethylamide de l’acide d-lysergique (LSD 25) sur le papio papio photosensible. Electroenceph. clin. Neurophysiol. 30, 294–305 (1971)
Wasson, R.G.: The hallucinogenic mushrooms of Mexico: An adventure in ethnomycological exploration. Trans. N. Y. Acad. Sci. 21, 325–336 (1959)
Weidmann, H., Cerletti, A.: Die Wirkung von d-lysergsäure-diäthylamid und 5-hydroxytryptamin (Serotonin) auf spinale Reflexe der Katze. Helv. physiol. pharmacol. Acta 15, 376–383 (1957)
Weidmann, H., Cerletti, A.: Studies on psilocybin and related componds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats. Helv. physiol. pharmacol. Acta 18, 174–182 (1960)
Wells, B.: Psychedelic drugs. New York: Jason Aronson 1974
Wikler, A.: Clinical and electroencephalographic studies on the effects of mescaline, N-allylnor-morphine and morphine in man. A pharmacologic analysis of the functions of the spontaneous electrical activity of the cerebral cortex. J. nerv. ment. Dis. 120, 157–175 (1954)
Wikler, A.: The relation of psychiatry to pharmacology. Baltimore: Williams & Wilkins Company 1957
Wilder, A., Haertzen, C.A., Chessick, R.D., Hill, H.E., Pescor, F.T.: Reaction time (“mental set”) in control and chronic schizophrenic subjects and in postaddicts under placebo, LSD-25, morphine, pentobarbital and amphetamine. Psychopharmacologia (Berl.) 7, 423–443 (1965)
Winter, C.A., Flataker, L.: Effects of lysergic acid diethylamide upon performance of trained rats. Proc. Soc. exp. Biol. (N. Y.) 92, 285–289 (1956)
Winter J.C.: Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: Absence of a metabolic component. J. Pharmacol. exp. Ther. 178, 625–630 (1971)
Winter, J.C.: A comparison of the stimulus properties of mescaline and 2,3,4-trimethoxy-phenyl-ethylamine. J. Pharmacol. exp. Ther. 185, 101–107 (1973)
Winter, J.C.: The effects of 3,4-dimethoxyphenylethylamine in rats trained with mescaline as a discriminative stimulus. J. Pharmacol. exp. Ther. 189, 741–747 (1974a)
Winter, J.C.: Hallucinogens as discriminative stimuli. Fed. Proc. 33, 1825–1832 (1974b)
Winters, W.D.: Neuropharmacological studies and postulates on excitation and depression in the central nervous system. In: Wortis, J. (Ed.): Recent advances in biological psychiatry, Vol.9. New York: Plenum Publishing Company 1967
Winters, W.D., Mori, K., Wallach, M.B., Mareus, R.J., Spooner, C.E.: Reticular multiple unit activity during a progression of states induced by CNS excitants. Electroenceph. clin. Neurophysiol. 27, 514–522 (1969)
Wolbach, A.B. Jr., Isbell, H., Miner, E.J.: Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacologia (Berl.) 3, 1–14 (1962a)
Wolbach, A.B. Jr., Miner, E.J., Isbell, H.: Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia (Berl.) 3, 219–223 (1962b)
Woolley, D.W.: The biochemical bases of psychoses or the serotonin hypothesis about mental diseases. New York: John Wiley and Sons, Inc. 1962
Woolley, D. W., Shaw, E.: Antimetabolites of serotonin. J. biol. Chem. 203, 69–79 (1953)
Woolley, D.W., Shaw, E.: A biochemical and pharmacological suggestion about certain mental disorders. Proc. nat. Acad. Sci. (Wash.) 40, 228–231 (1954a)
Woolley, D.W., Shaw, E.: Some neurophysiological aspects of serotonin. Brit. med. J. 1954 IIb, 122–126 (1954b)
Woolley, D.W., Shaw, E.N.: Evidence for the participation of serotonin in mental processes. Ann. N. Y. Acad. Sci. 66, 649–667 (1957)
Yamamoto, T., Ueki, S.: Behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) in rats and mice. Europ. J. Pharmacol. 31, 156–162 (1975)
Yui, T., Takeo, Y.: Neuropharmacological studies on a new series of ergot alkaloids. The effects on electrocorticogram of rabbits. Jap. J. Pharmacol. 7, 162–168 (1958)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Martin, W.R., Sloan, J.W. (1977). Pharmacology and Classification of LSD-like Hallucinogens. In: Martin, W.R. (eds) Drug Addiction II. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 45 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66709-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-66709-1_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66711-4
Online ISBN: 978-3-642-66709-1
eBook Packages: Springer Book Archive